Search for: "Boehringer Ingelheim Pharmaceuticals, Inc."
Results 21 - 40
of 124
Sorted by Relevance
|
Sort by Date
22 Mar 2012, 1:15 pm
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com) Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran. [read post]
22 Nov 2010, 11:14 am
Employment National origin discrimination Where an employee falsified his call records, summary judgment was properly granted to the employer on the claim that he was terminated because of his national origin. [read post]
25 Jul 2012, 12:42 pm
Two more plaintiffs have come forward seeking drug injury compensation from Boehringer Ingelheim Pharmaceuticals Inc. for the harm they have suffered from taking Pradaxa. [read post]
26 Dec 2012, 1:35 pm
A Look At The Events And The Evidence Leading Up To This Latest FDA Action Concerning The Safety Of Pradaxa (Posted by Tom Lamb at DrugInjuryWatch.com) We set the stage with this December 19, 2012 drug company press release, "Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
21 Mar 2012, 7:46 am
BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC., ET AL., App. [read post]
31 May 2010, 8:52 pm
Intervet Inc. et al. 1:10-cv-00435; filed May 25, 2010 in the District Court of Delaware • Plaintiff: Wyeth LLC • Defendants: Intervet Inc. d/b/a Intervet/Schering-Plough Animal Health; Boehringer Ingelheim Vetmedica Inc. [read post]
13 Feb 2014, 6:00 am
District Court Judge David Herndon from the Southern District of Illinois imposed close to $1 million in punitive damages on defendants Boehringer Ingelheim International GMBH (“BII”) and Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
3 Aug 2012, 4:45 am
A man from neighboring Tennessee has filed a lawsuit against Boehringer Ingelheim Pharmaceuticals, Inc., the maker of Pradaxa. [read post]
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
9 Jul 2018, 6:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc., 2018 WL 3028972 (CADC June 19, 2018). [read post]
15 Jan 2014, 5:43 am
Herndon of the Southern District of Illinois has ordered that Boehringer Ingelheim Pharmaceuticals, Inc. [read post]
17 Dec 2010, 11:05 am
Boehringer Ingelheim Pharmaceuticals, Inc., slip op. (8th Cir. [read post]
19 Dec 2010, 9:44 am
--Naik v Boehringer Ingelheim Pharm, Inc., 7thCir, November 22, 2010, No. 09-2960: Summary judgment upheld for employer after 53-year-old former pharmaceutical sales rep failed to show that termination based on falsification of call records, was pretext for age and national origin (Indian) discrimination in violation of the Age Discrimination in Employment Act (ADEA) and Title VII.The employer's legitimate non-discriminatory reason (LNDR) was pretty damning… [read post]
14 Mar 2012, 10:42 am
Boehringer Ingelheim Pharmaceuticals Inc., et al.; U.S. [read post]
28 Jul 2011, 11:19 am
Boehringer Ingelheim Pharmaceuticals, No. 10-3129, slip op. (8th Cir. [read post]
13 Nov 2019, 9:15 am
” Similarly, the Board held in Mylan Pharmaceuticals Inc. v. [read post]
21 Mar 2017, 12:23 pm
Boehringer Ingelheim Pharmaceuticals, Inc. markets this prescription anticoagulant drug. [read post]
20 Aug 2012, 11:15 am
Since coming on the market in October 2010 the FDA has received numerous Adverse Event Reports involving: • Serious bleeding side effects • Hemorrhages such as hemorrhagic stroke In addition, some medical studies have associated Pradaxa with an increased risk: • Heart attack • Myocardial infarction (MI)• Acute coronary syndrome (ACS) Due to these serious side effects, a growing number of personal injury and wrongful death Pradaxa lawsuits have been filed against… [read post]
11 Jan 2018, 12:30 pm
Boehringer Ingelheim Pharmaceuticals, Inc. is the drug company responsible for OFEV in the US. [read post]
17 Jan 2007, 5:24 am
The companies that have been sued to date are Amgen, Inc.; Astrazeneca Pharmaceuticals, L.P.; Bayer Corp.; Boehringer-Ingelheim Corp.; Eli Lilly, & Co.; GlaxoSmithKline, PLC; Hoffman-LaRoche, Inc.; Johnson & Johnson; Pfizer, Inc.; and Sanofi-Aventis U.S., Inc.Plaintiffs' claim in these cases is that the defendant erroneously classified pharmaceutical sales representatives as exempt from federal or state overtime… [read post]